News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Amir Meftah, MD

Dr Meftah is a psychiatry resident physician at One Brooklyn Health.

Articles by Amir Meftah, MD

New Africa /Adobestock

Poster at APA Annual Meeting Explores the Use of GLP-1 Agonists for Antipsychotic-Associated Metabolic Issues

ByAmir Meftah, MD,Heidi Anne Duerr, MPH

May 18th 2025

Can GLP-1 agonists support patients on antipsychotics? Amir Meftah, MD, and colleagues explore its use.

New Research on Addressing Metabolic Issues Associated With Antipsychotics at APA Annual Meeting

ByAmir Meftah, MD,Heidi Anne Duerr, MPH

May 17th 2025

Amir Meftah, MD, discusses the possibility of GLP-1s for addressing metabolic issues associated with antipsychotics.

Latest Updated Articles

Poster at APA Annual Meeting Explores the Use of GLP-1 Agonists for Antipsychotic-Associated Metabolic Issues
Published: May 18th 2025 | Updated:

Trending on Psychiatric Times

Whatever Happened to Psychopathology?

Yale Expertise in Pain, Trauma Techniques Help Ukrainian MDs During Month-Long Training

The “No Kings” Rallies: Tricks or Treats?

© 2025 MJH Life Sciences^®

All rights reserved.